Related Experiment Videos
Extracorporeal Life Support Registry Report 2004
Steven A Conrad1, Peter T Rycus, Heidi Dalton
1Louisiana State University Health Sciences Center, 1501 Kings Highway, P.O. Box 33932, Shreveport, LA 71130-3932, USA.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|March 5, 2005
Summary
Extracorporeal life support (ECLS) has benefited nearly 29,000 patients, with neonatal respiratory failure showing high survival rates. While neonatal cases have decreased, adult and pediatric respiratory failure survival remains consistent.
Area of Science:
- Critical Care Medicine
- Pediatrics
- Cardiology
Background:
- Extracorporeal Life Support Organization (ELSO) Registry data through July 2004 is analyzed.
- Nearly 29,000 patients have received extracorporeal life support (ECLS).
Purpose of the Study:
- To present trends and survival outcomes for ECLS across different age groups and conditions.
- To analyze the utilization and effectiveness of extracorporeal membrane oxygenation (ECMO).
Main Methods:
- Analysis of data from the international ELSO Registry Reports.
- Categorization of patients by age (neonatal, pediatric, adult) and condition (respiratory failure, cardiac failure).
Main Results:
- Neonatal respiratory failure (66% of cases) had a 77% survival rate, though case numbers have declined.
- Pediatric respiratory failure (56% survival) and adult respiratory failure (53% survival) showed consistent outcomes.
- Increasing use of ECLS for cardiac failure across all age groups with lower survival rates (33-43%).
Conclusions:
- ECLS remains a critical intervention for severe respiratory failure in neonates, pediatric, and adult patients.
- While neonatal respiratory failure cases have decreased, survival rates for respiratory failure in pediatric and adult patients remain stable.
- Cardiac failure support via ECLS is growing but associated with lower survival rates.